Episode 126: Oncology Clinical Trials and Drug Development

ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug trials, U.S. Food and Drug Administration (FDA) approvals in 2020, and what oncology nurses need to know about the process for oncology drug development. The advertising messages in this episode are sponsored by the University of Cincinnati Online.

Episode Notes 

Check out these resources from today’s episode:  

• Read the latest FDA updates on ONS Voice. 

• Oncology Nursing Podcast Episode 19: The Practical Side of Clinical Trials  

• Clinical Journal of Oncology Nursing article: Clinical Trials: Understanding Patient Perspectives and Beliefs About Treatment 

• ONS book: Manual for Clinical Trials Nursing (third edition) 

• ONS’s Oncology Clinical Trials Nurse Competencies 

• ONS webinar: Offering Clinical Trials Can Make a Difference 

• Clinicaltrials.gov 

• DailyMed 

To discuss the information in this episode with other oncology nurses, visit the ONS Communities.

To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.

Listen on:

Listen on Amazon Music, Listen on Apple Podcasts, Listen on Spotify, Listen on YouTube Music